{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:53:50Z","timestamp":1777452830068,"version":"3.51.4"},"reference-count":21,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Therapy"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:p>We describe two patients admitted to our institution with a diagnosis of sexually acquired acute hepatitis B who also had underlying hyper acute HIV infection. Both individuals reported high rates of condomless sex. Antiviral therapy active against HBV and HIV was started within days after diagnosis. Treatment was well tolerated and led to a rapid control of both infections and hepatitis B surface antibody seroconversion. The efficacy and safety of contemporary antiretroviral drug combinations suggest that treatment of acute HIV infection is feasible in patients with acute hepatitis B.<\/jats:p>","DOI":"10.3851\/imp3201","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T08:56:28Z","timestamp":1507798588000},"page":"197-200","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary HIV Infection in Patients with Acute Hepatitis B: A Report of Two Cases"],"prefix":"10.1177","volume":"23","author":[{"given":"Francesca","family":"Binda","sequence":"first","affiliation":[{"name":"Department of Biomedical and Clinical Sciences \u2018Luigi Sacco\u2019, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Monge","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences \u2018Luigi Sacco\u2019, University of Milan, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco R","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Department of Medicine, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Zanchetta","sequence":"additional","affiliation":[{"name":"Clinical Microbiology, Virology and Bioemergence Diagnostics, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences \u2018Luigi Sacco\u2019, University of Milan, Milan, Italy"},{"name":"III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Milazzo","sequence":"additional","affiliation":[{"name":"III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Corbellino","sequence":"additional","affiliation":[{"name":"III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spinello","family":"Antinori","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Clinical Sciences \u2018Luigi Sacco\u2019, University of Milan, Milan, Italy"},{"name":"III Division of Infectious Diseases, ASST Fatebenefratelli Sacco, Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,2,1]]},"reference":[{"key":"bibr1-IMP3201","unstructured":"World Health Organization. Global Hepatitis Report 2017. Geneva, 2017. (Accessed 4 May 2017.) Available from http:\/\/apps.who.int\/iris\/bitstream\/10665\/255016\/1\/9789241565455-eng.pdf?ua=1."},{"key":"bibr2-IMP3201","unstructured":"European Centre for Disease Prevention and Control. Hepatitis B surveillance in Europe \u2013 2013. Stockholm: ECDC; 2015. (Accessed 4 May 2017.) Available from http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/hepatitis-b-surveillance-in-europe-2013.pdf."},{"key":"bibr3-IMP3201","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/820506"},{"key":"bibr4-IMP3201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"bibr5-IMP3201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1507198"},{"key":"bibr6-IMP3201","doi-asserted-by":"publisher","DOI":"10.1086\/428777"},{"key":"bibr7-IMP3201","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000120"},{"key":"bibr8-IMP3201","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.7.3382"},{"key":"bibr9-IMP3201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110039"},{"key":"bibr10-IMP3201","doi-asserted-by":"publisher","DOI":"10.1086\/429411"},{"key":"bibr11-IMP3201","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"bibr12-IMP3201","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.02.010"},{"key":"bibr13-IMP3201","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22883"},{"key":"bibr14-IMP3201","doi-asserted-by":"crossref","first-page":"H3","DOI":"10.1177\/135965350701203S02","volume":"12","author":"McGovern B.H.","year":"2007","journal-title":"Antivir Ther"},{"key":"bibr15-IMP3201","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i46.17360"},{"key":"bibr16-IMP3201","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11913-1"},{"key":"bibr17-IMP3201","unstructured":"American Association for the Study of Liver Diseases. AASLD Position Paper: The Management of Acute Liver Failure: Update 2011. (Accessed 24 April 2017.) Available from https:\/\/www.aasld.org\/sites\/default\/files\/guideline_documents\/AcuteLiverFailureUpdate201journalformat1.pdf."},{"key":"bibr18-IMP3201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142515"},{"key":"bibr19-IMP3201","unstructured":"European Centre for Disease Prevention and Control. Hepatitis A outbreaks in the EU\/EEA mostly affecting men who have sex with men, Stockholm, December 2016. (Accessed 4 May 2017.) Available from http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/13-12-2016-RRA-Hepatitis%20A-United%20Kingdom.pdf."},{"key":"bibr20-IMP3201","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000180"},{"key":"bibr21-IMP3201","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit145"}],"container-title":["Antiviral Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3201","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3851\/IMP3201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:52:25Z","timestamp":1777380745000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3851\/IMP3201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.3851\/IMP3201"],"URL":"https:\/\/doi.org\/10.3851\/imp3201","relation":{},"ISSN":["1359-6535","2040-2058"],"issn-type":[{"value":"1359-6535","type":"print"},{"value":"2040-2058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}